T. Rowe backs Australia as sole geographic overweight

T Rowe Price Randal Jenneke australian equities

18 December 2020
| By Laura Dew |
image
image
expand image

Australian equities are the only developed market region where T. Rowe Price is holding an overweight position as the firm issues a “cautiously optimistic” outlook for the country for 2021.  

The firm said Australia had supportive valuations, decent dividend yield while earnings estimates were being revised higher. The ASX 200 had returned 1.9% since the start of the year to 16 December while the Small Ordinaries index had returned 7.8%. Unlike other countries, Australia also benefited from the lifting of lockdown restrictions and extensive fiscal and monetary support. 

The US had performed better than Australia with the S&P 500 seeing returns of 7.9% but T. Rowe Price said the US suffered from political volatility, rising COVID-19 cases and US dollar weakness. The FTSE 100 had lost 16% over the same period. 

Performance of S&P 500, ASX 200 and FTSE 100 since start of the year to 16 December 2020 

Randal Jenneke, head of Australian equities at T. Rowe Price, said: “We are cautiously optimistic towards Australian equities in 2021, the only developed equity market that is favoured as an overweight by our global multi-asset colleagues. 

“The Australian share market has supportive valuations, a decent dividend while FY20 earnings estimates have bottomed and are being revised higher. The market is also less at risk from a small number of highly-valued growth stocks, and returns this year have been more evenly distributed across sectors, including consumer discretionary and communication services.” 

He particularly highlighted quality growth companies such as medical devices manufacturer Resmed, recruitment group Seek Group and building firm James Hardie, all three of these stocks had seen returns of more than 20% since the start of the year. However, T. Rowe had taken profit on iron ore producers and the materials sector and questioned the sustainability of the rebound in travel stocks.  

Performance of three stocks versus ASX 200 since the start of the year to 16 December 2020 

 

Looking at earnings, Jenneke believed strong earnings would take until 2022 rather than 2021 despite the successful development of a COVID-19 vaccine.  

“For the market, the real story for earnings is more likely to concern 2022 rather than 2021, when investors will be looking for strong, sustainable earnings per share growth. At the macro level, there are still numerous risks to the earnings outlook for 2021, such as rising non-performing loans at the banks, weaker commodity prices and an assumption of no more lockdowns,” Jenneke said.  

Read more about:

AUTHOR

Recommended for you

sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

Completely agree Peter. The definition of 'significant change is circumstances relevant to the scope of the advice' is s...

1 month 3 weeks ago

This verdict highlights something deeply wrong and rotten at the heart of the FSCP. We are witnessing a heavy-handed, op...

1 month 4 weeks ago

Interesting. Would be good to know the details of the StrategyOne deal....

2 months ago

SuperRatings has shared the median estimated return for balanced superannuation funds for the calendar year 2024, finding the year achieved “strong and consistent positiv...

2 weeks 1 day ago

Original bidder Bain Capital, which saw its first offer rejected in December, has returned with a revised bid for Insignia Financial....

1 week 1 day ago

The FAAA has secured CSLR-related documents under the FOI process, after an extended four-month wait, which show little analysis was done on how the scheme’s cost would a...

6 days 8 hours ago

TOP PERFORMING FUNDS